Jerry Ware
Concepts (434)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 54 | 2025 | 259 | 7.060 |
Why?
| | Platelet Glycoprotein GPIb-IX Complex | 37 | 2022 | 51 | 4.460 |
Why?
| | Thrombosis | 17 | 2023 | 253 | 2.810 |
Why?
| | Hemostasis | 15 | 2025 | 60 | 2.590 |
Why?
| | von Willebrand Factor | 15 | 2022 | 44 | 2.070 |
Why?
| | Platelet Membrane Glycoproteins | 15 | 2025 | 22 | 2.010 |
Why?
| | Cell-Derived Microparticles | 6 | 2018 | 20 | 1.630 |
Why?
| | Platelet Activation | 14 | 2020 | 47 | 1.600 |
Why?
| | Bernard-Soulier Syndrome | 7 | 2022 | 7 | 1.570 |
Why?
| | Sepsis | 4 | 2018 | 239 | 1.340 |
Why?
| | von Willebrand Diseases | 5 | 2016 | 25 | 1.150 |
Why?
| | Animals | 71 | 2025 | 13505 | 1.110 |
Why?
| | Thrombocytopenia | 9 | 2019 | 89 | 1.000 |
Why?
| | Mice | 50 | 2025 | 5949 | 0.970 |
Why?
| | Inflammation | 7 | 2023 | 641 | 0.950 |
Why?
| | Thrombin | 7 | 2016 | 37 | 0.910 |
Why?
| | Neoplasms | 4 | 2019 | 1325 | 0.910 |
Why?
| | Cell Cycle Proteins | 6 | 2006 | 169 | 0.900 |
Why?
| | Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2013 | 33 | 0.880 |
Why?
| | Platelet Aggregation | 14 | 2023 | 72 | 0.850 |
Why?
| | Mice, Knockout | 25 | 2025 | 879 | 0.850 |
Why?
| | Hemorrhage | 7 | 2018 | 209 | 0.830 |
Why?
| | Carcinoma, Lewis Lung | 2 | 2012 | 9 | 0.720 |
Why?
| | Melanoma, Experimental | 2 | 2012 | 40 | 0.700 |
Why?
| | Mice, Inbred C57BL | 25 | 2025 | 1884 | 0.680 |
Why?
| | Mice, Transgenic | 23 | 2019 | 552 | 0.660 |
Why?
| | Signal Transduction | 13 | 2025 | 1671 | 0.650 |
Why?
| | Disease Models, Animal | 17 | 2022 | 1478 | 0.630 |
Why?
| | Renal Insufficiency, Chronic | 4 | 2023 | 187 | 0.620 |
Why?
| | Klebsiella Infections | 2 | 2018 | 13 | 0.610 |
Why?
| | Klebsiella pneumoniae | 2 | 2018 | 20 | 0.610 |
Why?
| | Pneumonia, Bacterial | 2 | 2018 | 32 | 0.610 |
Why?
| | Phosphatidylserines | 1 | 2018 | 3 | 0.600 |
Why?
| | Haplotypes | 1 | 2018 | 92 | 0.600 |
Why?
| | Phenotype | 10 | 2018 | 789 | 0.570 |
Why?
| | Receptors, Proteinase-Activated | 3 | 2016 | 5 | 0.550 |
Why?
| | Megakaryocytes | 6 | 2017 | 19 | 0.550 |
Why?
| | Cytoskeletal Proteins | 5 | 2006 | 48 | 0.540 |
Why?
| | Humans | 60 | 2023 | 52483 | 0.520 |
Why?
| | GTP Phosphohydrolases | 4 | 2004 | 30 | 0.520 |
Why?
| | Hemorrhagic Disorders | 2 | 2013 | 6 | 0.520 |
Why?
| | Blood Platelet Disorders | 3 | 2016 | 6 | 0.500 |
Why?
| | GTP-Binding Proteins | 3 | 2006 | 85 | 0.490 |
Why?
| | Point Mutation | 2 | 2013 | 67 | 0.480 |
Why?
| | von Willebrand Disease, Type 2 | 1 | 2013 | 2 | 0.440 |
Why?
| | Amino Acid Substitution | 1 | 2013 | 82 | 0.430 |
Why?
| | Mutation, Missense | 1 | 2013 | 108 | 0.410 |
Why?
| | Platelet Transfusion | 6 | 2020 | 33 | 0.410 |
Why?
| | Cell Lineage | 1 | 2013 | 85 | 0.410 |
Why?
| | RNA Splicing | 1 | 2013 | 41 | 0.410 |
Why?
| | Blood Preservation | 3 | 2020 | 27 | 0.400 |
Why?
| | Endothelium, Vascular | 3 | 2013 | 246 | 0.400 |
Why?
| | Protein Binding | 12 | 2021 | 667 | 0.400 |
Why?
| | Communicable Diseases | 1 | 2013 | 55 | 0.400 |
Why?
| | Single-Chain Antibodies | 1 | 2012 | 21 | 0.390 |
Why?
| | Lung Neoplasms | 2 | 2009 | 636 | 0.380 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2012 | 236 | 0.350 |
Why?
| | Tumor Microenvironment | 1 | 2012 | 256 | 0.340 |
Why?
| | Blood Coagulation | 5 | 2018 | 64 | 0.340 |
Why?
| | Platelet Adhesiveness | 5 | 2013 | 13 | 0.340 |
Why?
| | Collagen | 7 | 2016 | 211 | 0.330 |
Why?
| | Neutrophils | 4 | 2018 | 147 | 0.330 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2010 | 74 | 0.330 |
Why?
| | Gene Deletion | 3 | 2007 | 272 | 0.320 |
Why?
| | Cold Temperature | 2 | 2020 | 53 | 0.310 |
Why?
| | Venous Thrombosis | 3 | 2018 | 90 | 0.310 |
Why?
| | Septins | 7 | 2006 | 20 | 0.310 |
Why?
| | Mutation | 4 | 2016 | 1347 | 0.300 |
Why?
| | Membrane Glycoproteins | 4 | 2013 | 244 | 0.290 |
Why?
| | Recombinant Fusion Proteins | 3 | 2013 | 177 | 0.270 |
Why?
| | Blood Vessels | 2 | 2020 | 71 | 0.260 |
Why?
| | Bleeding Time | 5 | 2014 | 9 | 0.260 |
Why?
| | Tubulin | 1 | 2006 | 21 | 0.260 |
Why?
| | Microtubules | 1 | 2006 | 39 | 0.250 |
Why?
| | Membrane Proteins | 3 | 2004 | 335 | 0.250 |
Why?
| | Jugular Veins | 1 | 2025 | 34 | 0.240 |
Why?
| | Vena Cava, Inferior | 2 | 2018 | 65 | 0.240 |
Why?
| | Monocytes | 3 | 2018 | 130 | 0.230 |
Why?
| | Blood Proteins | 2 | 2018 | 85 | 0.230 |
Why?
| | Immunoglobulins, Intravenous | 2 | 2017 | 63 | 0.220 |
Why?
| | Platelet Aggregation Inhibitors | 5 | 2023 | 181 | 0.220 |
Why?
| | Male | 18 | 2023 | 26761 | 0.220 |
Why?
| | Ligands | 4 | 2014 | 206 | 0.220 |
Why?
| | Bone and Bones | 1 | 2008 | 494 | 0.220 |
Why?
| | Flow Cytometry | 5 | 2013 | 478 | 0.210 |
Why?
| | Nerve Tissue Proteins | 2 | 2002 | 187 | 0.210 |
Why?
| | Tumor Escape | 2 | 2015 | 17 | 0.210 |
Why?
| | Neovascularization, Pathologic | 3 | 2015 | 153 | 0.210 |
Why?
| | Female | 16 | 2023 | 28171 | 0.210 |
Why?
| | Receptors, Interleukin-4 | 1 | 2002 | 4 | 0.200 |
Why?
| | Cell Communication | 2 | 2014 | 71 | 0.200 |
Why?
| | Antibodies, Monoclonal | 5 | 2017 | 481 | 0.200 |
Why?
| | Platelet Count | 5 | 2023 | 75 | 0.200 |
Why?
| | Neoplasm Invasiveness | 2 | 2015 | 278 | 0.190 |
Why?
| | Integrins | 2 | 2020 | 31 | 0.190 |
Why?
| | Time Factors | 7 | 2020 | 2968 | 0.190 |
Why?
| | Homeostasis | 2 | 2020 | 201 | 0.190 |
Why?
| | Thrombopoiesis | 3 | 2011 | 5 | 0.190 |
Why?
| | Calcium | 3 | 2020 | 376 | 0.190 |
Why?
| | Radiation Protection | 1 | 2021 | 47 | 0.180 |
Why?
| | Egtazic Acid | 1 | 2020 | 11 | 0.180 |
Why?
| | Tail | 3 | 2014 | 10 | 0.170 |
Why?
| | Severity of Illness Index | 2 | 2018 | 1026 | 0.160 |
Why?
| | Case-Control Studies | 2 | 2023 | 1201 | 0.160 |
Why?
| | Arthritis, Experimental | 2 | 2017 | 10 | 0.160 |
Why?
| | Sertraline | 1 | 2019 | 44 | 0.160 |
Why?
| | Protein Structure, Tertiary | 5 | 2013 | 242 | 0.160 |
Why?
| | Synovial Membrane | 2 | 2017 | 19 | 0.160 |
Why?
| | Melioidosis | 1 | 2019 | 1 | 0.160 |
Why?
| | Burkholderia pseudomallei | 1 | 2019 | 4 | 0.160 |
Why?
| | Cell Proliferation | 2 | 2015 | 1023 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-kit | 2 | 2017 | 33 | 0.150 |
Why?
| | Gray Platelet Syndrome | 1 | 2018 | 1 | 0.150 |
Why?
| | Age of Onset | 1 | 2018 | 110 | 0.150 |
Why?
| | Thrombopoietin | 1 | 2018 | 9 | 0.150 |
Why?
| | Genetic Predisposition to Disease | 2 | 2018 | 528 | 0.150 |
Why?
| | Multiple Organ Failure | 1 | 2018 | 49 | 0.150 |
Why?
| | src-Family Kinases | 2 | 2009 | 34 | 0.150 |
Why?
| | Depressive Disorder, Major | 1 | 2019 | 148 | 0.150 |
Why?
| | Genetic Association Studies | 1 | 2018 | 122 | 0.140 |
Why?
| | Cell Differentiation | 3 | 2011 | 665 | 0.140 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2017 | 11 | 0.140 |
Why?
| | Refrigeration | 1 | 2017 | 4 | 0.140 |
Why?
| | Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 24 | 0.140 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2017 | 6 | 0.140 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2017 | 11 | 0.140 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2022 | 399 | 0.140 |
Why?
| | Mechanotransduction, Cellular | 1 | 2017 | 42 | 0.140 |
Why?
| | Cytokines | 3 | 2022 | 623 | 0.140 |
Why?
| | Cell Line, Tumor | 3 | 2018 | 1470 | 0.140 |
Why?
| | Recombinant Proteins | 6 | 2018 | 483 | 0.130 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2016 | 16 | 0.130 |
Why?
| | Glycosphingolipids | 1 | 2016 | 3 | 0.130 |
Why?
| | Membrane Microdomains | 1 | 2016 | 12 | 0.130 |
Why?
| | Receptors, Purinergic P2 | 2 | 2009 | 26 | 0.130 |
Why?
| | Microfilament Proteins | 2 | 2016 | 43 | 0.130 |
Why?
| | Plaque, Atherosclerotic | 1 | 2016 | 44 | 0.120 |
Why?
| | Lentivirus | 2 | 2014 | 17 | 0.120 |
Why?
| | Disease Progression | 1 | 2018 | 871 | 0.120 |
Why?
| | Liver | 2 | 2019 | 1156 | 0.120 |
Why?
| | Lectins, C-Type | 3 | 2020 | 31 | 0.120 |
Why?
| | Anticarcinogenic Agents | 1 | 2015 | 32 | 0.120 |
Why?
| | Amino Acid Sequence | 3 | 2013 | 578 | 0.120 |
Why?
| | Liver Neoplasms | 1 | 2019 | 333 | 0.120 |
Why?
| | Pancreatic Neoplasms | 1 | 2018 | 216 | 0.120 |
Why?
| | Phosphorylation | 4 | 2006 | 528 | 0.120 |
Why?
| | Molecular Sequence Data | 3 | 2013 | 778 | 0.120 |
Why?
| | Protein Subunits | 2 | 2007 | 79 | 0.120 |
Why?
| | Carotid Artery Thrombosis | 1 | 2014 | 4 | 0.120 |
Why?
| | Cell Death | 1 | 2015 | 177 | 0.110 |
Why?
| | Busulfan | 1 | 2014 | 17 | 0.110 |
Why?
| | Genetic Therapy | 2 | 2014 | 121 | 0.110 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 243 | 0.110 |
Why?
| | Neovascularization, Physiologic | 1 | 2014 | 72 | 0.110 |
Why?
| | Neoplastic Stem Cells | 1 | 2015 | 99 | 0.110 |
Why?
| | Macrophage-1 Antigen | 1 | 2014 | 6 | 0.110 |
Why?
| | Mice, 129 Strain | 1 | 2014 | 37 | 0.110 |
Why?
| | Aspirin | 1 | 2015 | 115 | 0.110 |
Why?
| | Interleukin-4 | 1 | 2014 | 44 | 0.110 |
Why?
| | Ligation | 1 | 2014 | 60 | 0.110 |
Why?
| | Collagen Type IV | 1 | 2013 | 12 | 0.110 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2013 | 9 | 0.110 |
Why?
| | Transplantation Conditioning | 1 | 2014 | 93 | 0.110 |
Why?
| | Cecum | 1 | 2014 | 61 | 0.110 |
Why?
| | Adenocarcinoma | 1 | 2018 | 405 | 0.110 |
Why?
| | Fibrinogen | 3 | 2009 | 34 | 0.110 |
Why?
| | Dermatitis, Contact | 1 | 2013 | 3 | 0.110 |
Why?
| | Antibodies, Blocking | 1 | 2013 | 6 | 0.110 |
Why?
| | Immune Complex Diseases | 1 | 2013 | 6 | 0.110 |
Why?
| | Atherosclerosis | 1 | 2016 | 219 | 0.110 |
Why?
| | Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2013 | 4 | 0.110 |
Why?
| | Endotoxemia | 1 | 2013 | 34 | 0.110 |
Why?
| | DNA-Binding Proteins | 1 | 2016 | 422 | 0.100 |
Why?
| | Platelet Membrane Glycoprotein IIb | 2 | 2009 | 5 | 0.100 |
Why?
| | Cell Membrane | 4 | 2012 | 245 | 0.100 |
Why?
| | Contractile Proteins | 1 | 2011 | 5 | 0.100 |
Why?
| | Models, Biological | 1 | 2015 | 735 | 0.100 |
Why?
| | Histocompatibility, Maternal-Fetal | 1 | 2011 | 1 | 0.090 |
Why?
| | Receptors, Fc | 1 | 2011 | 10 | 0.090 |
Why?
| | Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 45 | 0.090 |
Why?
| | Abortion, Spontaneous | 1 | 2011 | 21 | 0.090 |
Why?
| | Cyclooxygenase 1 | 1 | 2011 | 7 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2018 | 2867 | 0.090 |
Why?
| | Epoprostenol | 1 | 2011 | 16 | 0.090 |
Why?
| | Genetic Vectors | 1 | 2011 | 128 | 0.090 |
Why?
| | Peptides | 3 | 2018 | 223 | 0.090 |
Why?
| | Synovitis | 1 | 2011 | 20 | 0.090 |
Why?
| | Genotype | 3 | 2017 | 566 | 0.090 |
Why?
| | Serotonin | 1 | 2012 | 146 | 0.090 |
Why?
| | Plateletpheresis | 1 | 2010 | 7 | 0.090 |
Why?
| | Bone Marrow Cells | 2 | 2009 | 190 | 0.090 |
Why?
| | Down-Regulation | 1 | 2012 | 346 | 0.090 |
Why?
| | P-Selectin | 3 | 2019 | 30 | 0.090 |
Why?
| | Adolescent | 2 | 2019 | 6739 | 0.080 |
Why?
| | Tumor Burden | 1 | 2010 | 136 | 0.080 |
Why?
| | Infant | 1 | 2018 | 3733 | 0.080 |
Why?
| | Synovial Fluid | 1 | 2010 | 17 | 0.080 |
Why?
| | Risk Factors | 1 | 2018 | 3889 | 0.080 |
Why?
| | Anaphylaxis | 1 | 2010 | 69 | 0.080 |
Why?
| | Killer Cells, Natural | 1 | 2010 | 116 | 0.080 |
Why?
| | Child, Preschool | 1 | 2018 | 4076 | 0.080 |
Why?
| | Carotid Artery Injuries | 1 | 2009 | 13 | 0.080 |
Why?
| | Transplantation, Isogeneic | 1 | 2009 | 2 | 0.080 |
Why?
| | Immunoprecipitation | 2 | 2011 | 57 | 0.080 |
Why?
| | Crosses, Genetic | 1 | 2009 | 34 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2009 | 86 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2009 | 138 | 0.080 |
Why?
| | Haploidy | 1 | 2009 | 4 | 0.080 |
Why?
| | Arthritis, Rheumatoid | 1 | 2010 | 116 | 0.080 |
Why?
| | Protein Transport | 2 | 2011 | 180 | 0.080 |
Why?
| | Protein Conformation | 3 | 2017 | 176 | 0.080 |
Why?
| | Cells, Cultured | 5 | 2018 | 1567 | 0.080 |
Why?
| | Embryonic Stem Cells | 1 | 2008 | 16 | 0.080 |
Why?
| | Metalloproteases | 1 | 2008 | 10 | 0.080 |
Why?
| | Receptors, Collagen | 2 | 2010 | 3 | 0.070 |
Why?
| | Splenomegaly | 1 | 2008 | 12 | 0.070 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2013 | 137 | 0.070 |
Why?
| | Protein Structure, Secondary | 1 | 2008 | 71 | 0.070 |
Why?
| | Chromosomes | 1 | 2007 | 30 | 0.070 |
Why?
| | Hepatocytes | 2 | 2019 | 190 | 0.070 |
Why?
| | Apoptosis | 2 | 2020 | 1119 | 0.070 |
Why?
| | Neoplasm Proteins | 1 | 2009 | 334 | 0.070 |
Why?
| | Nocodazole | 1 | 2006 | 4 | 0.070 |
Why?
| | Receptors, IgG | 2 | 2003 | 24 | 0.060 |
Why?
| | Cell Adhesion Molecules | 1 | 2006 | 86 | 0.060 |
Why?
| | Bone Marrow | 2 | 2011 | 364 | 0.060 |
Why?
| | Tubulin Modulators | 1 | 2006 | 27 | 0.060 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2006 | 87 | 0.060 |
Why?
| | Child | 1 | 2018 | 7248 | 0.060 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2006 | 134 | 0.060 |
Why?
| | Collagen Type I | 1 | 2006 | 83 | 0.060 |
Why?
| | Structure-Activity Relationship | 2 | 2017 | 404 | 0.060 |
Why?
| | Thromboplastin | 2 | 2018 | 4 | 0.060 |
Why?
| | Adenosine Triphosphate | 1 | 2006 | 205 | 0.060 |
Why?
| | Punctures | 1 | 2025 | 52 | 0.060 |
Why?
| | Consensus Sequence | 1 | 2004 | 22 | 0.060 |
Why?
| | Osteoclasts | 1 | 2008 | 428 | 0.060 |
Why?
| | Ploidies | 1 | 2004 | 10 | 0.060 |
Why?
| | COS Cells | 1 | 2004 | 73 | 0.060 |
Why?
| | Mice, Inbred BALB C | 2 | 2018 | 312 | 0.060 |
Why?
| | 14-3-3 Proteins | 1 | 2004 | 18 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 1 | 2004 | 111 | 0.060 |
Why?
| | Blood Cell Count | 1 | 2004 | 37 | 0.060 |
Why?
| | CHO Cells | 3 | 2016 | 125 | 0.060 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2004 | 78 | 0.060 |
Why?
| | Receptors, Thrombin | 2 | 2014 | 11 | 0.050 |
Why?
| | Receptors, Cell Surface | 1 | 2004 | 118 | 0.050 |
Why?
| | Proto-Oncogene Proteins | 1 | 2004 | 151 | 0.050 |
Why?
| | Melanoma | 1 | 2007 | 288 | 0.050 |
Why?
| | Interleukin-1 | 2 | 2017 | 107 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2004 | 169 | 0.050 |
Why?
| | Crotalid Venoms | 1 | 2003 | 8 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 291 | 0.050 |
Why?
| | Saccharomyces cerevisiae | 1 | 2004 | 176 | 0.050 |
Why?
| | Mutagenesis | 1 | 2003 | 61 | 0.050 |
Why?
| | Cell Size | 1 | 2002 | 45 | 0.050 |
Why?
| | Albuminuria | 1 | 2022 | 49 | 0.050 |
Why?
| | Adenosine | 1 | 2023 | 71 | 0.050 |
Why?
| | Ticlopidine | 1 | 2023 | 56 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2002 | 69 | 0.050 |
Why?
| | Terminology as Topic | 1 | 2002 | 70 | 0.050 |
Why?
| | Middle Aged | 4 | 2023 | 13028 | 0.050 |
Why?
| | Tetradecanoylphorbol Acetate | 1 | 2002 | 46 | 0.050 |
Why?
| | In Situ Hybridization | 1 | 2002 | 64 | 0.050 |
Why?
| | Neurotransmitter Agents | 1 | 2002 | 34 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2002 | 140 | 0.050 |
Why?
| | Fibroblasts | 2 | 2017 | 355 | 0.050 |
Why?
| | Synapses | 1 | 2002 | 74 | 0.050 |
Why?
| | Transgenes | 2 | 2014 | 51 | 0.040 |
Why?
| | Phospholipase C gamma | 1 | 2020 | 4 | 0.040 |
Why?
| | Meninges | 1 | 2020 | 13 | 0.040 |
Why?
| | RNA, Messenger | 1 | 2004 | 1132 | 0.040 |
Why?
| | Integrin beta3 | 2 | 2011 | 6 | 0.040 |
Why?
| | Up-Regulation | 1 | 2002 | 454 | 0.040 |
Why?
| | E-Selectin | 1 | 2019 | 13 | 0.040 |
Why?
| | Intention to Treat Analysis | 1 | 2019 | 30 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2019 | 34 | 0.040 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2013 | 56 | 0.040 |
Why?
| | Placebos | 1 | 2019 | 85 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 124 | 0.040 |
Why?
| | Kupffer Cells | 1 | 2019 | 12 | 0.040 |
Why?
| | Endothelium | 1 | 2019 | 37 | 0.040 |
Why?
| | Asia, Southeastern | 1 | 2019 | 5 | 0.040 |
Why?
| | Cytoplasmic Granules | 1 | 2019 | 21 | 0.040 |
Why?
| | Hyaluronic Acid | 1 | 2019 | 38 | 0.040 |
Why?
| | Peroxidase | 1 | 2018 | 17 | 0.040 |
Why?
| | N-Acetylneuraminic Acid | 1 | 2018 | 13 | 0.040 |
Why?
| | Pancreatic Elastase | 1 | 2018 | 16 | 0.040 |
Why?
| | Bacteriocins | 1 | 2018 | 2 | 0.040 |
Why?
| | Phosphatidylethanolamines | 1 | 2018 | 11 | 0.040 |
Why?
| | Transfection | 3 | 2004 | 357 | 0.040 |
Why?
| | Factor Xa | 1 | 2018 | 7 | 0.040 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2018 | 87 | 0.040 |
Why?
| | Glycosylation | 1 | 2018 | 106 | 0.040 |
Why?
| | Protein Unfolding | 1 | 2017 | 7 | 0.040 |
Why?
| | Shear Strength | 1 | 2017 | 10 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2019 | 713 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2017 | 90 | 0.040 |
Why?
| | Cell Polarity | 1 | 2017 | 16 | 0.030 |
Why?
| | NF-E2 Transcription Factor, p45 Subunit | 1 | 2017 | 3 | 0.030 |
Why?
| | Skin | 1 | 2020 | 422 | 0.030 |
Why?
| | Drug Design | 1 | 2018 | 120 | 0.030 |
Why?
| | Protein Processing, Post-Translational | 1 | 2018 | 153 | 0.030 |
Why?
| | Survival Analysis | 1 | 2019 | 673 | 0.030 |
Why?
| | Adenosine Diphosphate | 1 | 2016 | 19 | 0.030 |
Why?
| | Blood Coagulation Tests | 1 | 2016 | 20 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2018 | 144 | 0.030 |
Why?
| | Body Weight | 1 | 2019 | 523 | 0.030 |
Why?
| | Mast Cells | 1 | 2017 | 55 | 0.030 |
Why?
| | Fibrinolytic Agents | 1 | 2018 | 128 | 0.030 |
Why?
| | Molecular Targeted Therapy | 1 | 2018 | 133 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2016 | 4 | 0.030 |
Why?
| | Receptors, Purinergic P2Y12 | 2 | 2009 | 13 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2017 | 195 | 0.030 |
Why?
| | Blood Component Removal | 1 | 2016 | 15 | 0.030 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 56 | 0.030 |
Why?
| | Cricetulus | 1 | 2016 | 104 | 0.030 |
Why?
| | Gryllidae | 2 | 1986 | 5 | 0.030 |
Why?
| | Orthoptera | 2 | 1986 | 5 | 0.030 |
Why?
| | DNA, Ribosomal | 2 | 1986 | 26 | 0.030 |
Why?
| | Mice, SCID | 1 | 2016 | 182 | 0.030 |
Why?
| | Brain | 1 | 2004 | 1323 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2016 | 55 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2016 | 56 | 0.030 |
Why?
| | Endothelial Cells | 1 | 2017 | 262 | 0.030 |
Why?
| | Kinetics | 1 | 2016 | 626 | 0.030 |
Why?
| | Gene Transfer Techniques | 1 | 2014 | 40 | 0.030 |
Why?
| | Immune System | 1 | 2014 | 42 | 0.030 |
Why?
| | Tyrosine | 2 | 2006 | 87 | 0.030 |
Why?
| | Base Sequence | 3 | 2003 | 640 | 0.030 |
Why?
| | Hydroxylation | 1 | 2013 | 62 | 0.030 |
Why?
| | Cell Adhesion | 2 | 2006 | 163 | 0.030 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2013 | 13 | 0.030 |
Why?
| | Cattle | 1 | 2013 | 205 | 0.030 |
Why?
| | Proteolysis | 1 | 2013 | 101 | 0.030 |
Why?
| | Adoptive Transfer | 1 | 2013 | 29 | 0.030 |
Why?
| | Prospective Studies | 1 | 2019 | 2481 | 0.020 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2013 | 179 | 0.020 |
Why?
| | Immunosuppressive Agents | 1 | 2014 | 243 | 0.020 |
Why?
| | Ferric Compounds | 1 | 2012 | 17 | 0.020 |
Why?
| | Cricetinae | 2 | 2003 | 194 | 0.020 |
Why?
| | Blotting, Western | 1 | 2013 | 590 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2013 | 292 | 0.020 |
Why?
| | Factor XII | 1 | 2012 | 2 | 0.020 |
Why?
| | Binding Sites | 2 | 2003 | 377 | 0.020 |
Why?
| | Chlorides | 1 | 2012 | 46 | 0.020 |
Why?
| | rab4 GTP-Binding Proteins | 1 | 2012 | 7 | 0.020 |
Why?
| | Transglutaminases | 1 | 2012 | 14 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2023 | 5422 | 0.020 |
Why?
| | Phosphoproteins | 1 | 2013 | 119 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2013 | 206 | 0.020 |
Why?
| | Thrombocytopenia, Neonatal Alloimmune | 1 | 2011 | 4 | 0.020 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2013 | 202 | 0.020 |
Why?
| | Immunoblotting | 1 | 2011 | 116 | 0.020 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2011 | 48 | 0.020 |
Why?
| | Bone Marrow Transplantation | 1 | 2011 | 113 | 0.020 |
Why?
| | Antibodies | 1 | 2011 | 159 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 3392 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2010 | 20 | 0.020 |
Why?
| | Sodium Chloride | 1 | 2010 | 56 | 0.020 |
Why?
| | Proline | 1 | 2009 | 31 | 0.020 |
Why?
| | Arthritis | 1 | 2010 | 41 | 0.020 |
Why?
| | Hematopoietic Stem Cells | 1 | 2011 | 187 | 0.020 |
Why?
| | Hypersensitivity | 1 | 2010 | 81 | 0.020 |
Why?
| | Blood Pressure | 1 | 2012 | 537 | 0.020 |
Why?
| | Extracellular Matrix | 1 | 2010 | 112 | 0.020 |
Why?
| | Frameshift Mutation | 1 | 2009 | 18 | 0.020 |
Why?
| | Gene Expression | 1 | 2011 | 618 | 0.020 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2014 | 603 | 0.020 |
Why?
| | Young Adult | 1 | 2019 | 4329 | 0.020 |
Why?
| | Family Health | 1 | 2009 | 79 | 0.020 |
Why?
| | Genes | 2 | 1986 | 31 | 0.020 |
Why?
| | DNA Mutational Analysis | 1 | 2009 | 180 | 0.020 |
Why?
| | Dipeptides | 1 | 2008 | 21 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 2008 | 61 | 0.020 |
Why?
| | Genome | 1 | 2007 | 62 | 0.020 |
Why?
| | Arteries | 1 | 2007 | 92 | 0.020 |
Why?
| | Pseudopodia | 1 | 2006 | 5 | 0.020 |
Why?
| | Interleukin-4 Receptor alpha Subunit | 1 | 2006 | 2 | 0.020 |
Why?
| | Models, Animal | 1 | 2007 | 234 | 0.020 |
Why?
| | Arterioles | 1 | 2006 | 33 | 0.020 |
Why?
| | Adult | 2 | 2019 | 14161 | 0.020 |
Why?
| | Laminin | 1 | 2006 | 19 | 0.020 |
Why?
| | C-Reactive Protein | 1 | 2006 | 155 | 0.020 |
Why?
| | Cornea | 1 | 2006 | 53 | 0.020 |
Why?
| | Fibroblast Growth Factors | 1 | 2006 | 46 | 0.020 |
Why?
| | Proteoglycans | 1 | 2006 | 87 | 0.020 |
Why?
| | Drug Combinations | 1 | 2006 | 132 | 0.020 |
Why?
| | Glycoproteins | 1 | 2006 | 122 | 0.010 |
Why?
| | Pyrimidines | 1 | 2006 | 199 | 0.010 |
Why?
| | Hemoglobins | 1 | 2006 | 112 | 0.010 |
Why?
| | RNA, Ribosomal | 1 | 1985 | 18 | 0.010 |
Why?
| | Aged | 1 | 2019 | 10121 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 230 | 0.010 |
Why?
| | Pregnancy | 1 | 2011 | 2680 | 0.010 |
Why?
| | Agglutination Tests | 1 | 2004 | 5 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 2004 | 32 | 0.010 |
Why?
| | Hydrogen Bonding | 1 | 2003 | 35 | 0.010 |
Why?
| | Crystallization | 1 | 2003 | 33 | 0.010 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 235 | 0.010 |
Why?
| | DNA, Complementary | 1 | 2003 | 135 | 0.010 |
Why?
| | Alprostadil | 1 | 2003 | 10 | 0.010 |
Why?
| | Crystallography, X-Ray | 1 | 2003 | 156 | 0.010 |
Why?
| | Heterozygote | 1 | 2003 | 90 | 0.010 |
Why?
| | DNA Primers | 1 | 2003 | 208 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2003 | 91 | 0.010 |
Why?
| | Alternative Splicing | 1 | 2002 | 62 | 0.010 |
Why?
| | Cell Fractionation | 1 | 2002 | 10 | 0.010 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2002 | 19 | 0.010 |
Why?
| | Models, Molecular | 1 | 2003 | 348 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2002 | 75 | 0.010 |
Why?
| | Dimerization | 1 | 2002 | 51 | 0.010 |
Why?
| | Zinc Fingers | 1 | 2002 | 23 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2002 | 31 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 1 | 2002 | 46 | 0.010 |
Why?
| | Electrophysiology | 1 | 2002 | 68 | 0.010 |
Why?
| | Brain Chemistry | 1 | 2002 | 68 | 0.010 |
Why?
| | Phylogeny | 1 | 2002 | 231 | 0.010 |
Why?
| | Fungal Proteins | 1 | 2002 | 117 | 0.010 |
Why?
| | Plasmids | 1 | 2002 | 163 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2004 | 891 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2002 | 109 | 0.010 |
Why?
| | Microscopy, Fluorescence | 1 | 2002 | 160 | 0.010 |
Why?
| | Cell Line | 1 | 2004 | 1030 | 0.010 |
Why?
| | Cell Movement | 1 | 2002 | 268 | 0.010 |
Why?
| | Hippocampus | 1 | 2002 | 201 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2002 | 1378 | 0.010 |
Why?
| | DNA Restriction Enzymes | 2 | 1986 | 19 | 0.010 |
Why?
| | Repetitive Sequences, Nucleic Acid | 2 | 1986 | 90 | 0.010 |
Why?
| | Cloning, Molecular | 2 | 1986 | 190 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1986 | 47 | 0.000 |
Why?
| | Transcription, Genetic | 1 | 1986 | 378 | 0.000 |
Why?
| | Molecular Weight | 1 | 1985 | 82 | 0.000 |
Why?
| | Escherichia coli | 1 | 1985 | 192 | 0.000 |
Why?
|
|
Ware's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|